Proliant's state-of-the-art, Bovine Serum Albumin (BSA) production facility, is centrally located in the United States. Spanning 50,000 square feet, including a 10,000 square foot lyophilization suite, allows for extensive production capacity.
The facility is utilizes a closed membrane and centrifuge system, ensuring there is no environmental exposure. It is also computer-assisted process control with 100% stainless steel tanks, piping and is fully Clean In Place (CIP).
With the system that is in place, Proliant's Boone facility is FDA Bulk Pharmaceutical Chemical GMP's, USDA APHIS Registered and Inspected.
Feilding, New Zealand
Proliant will open its second manufacturing location in the first quarter of 2016. The facility is a mirror image of the Boone facility, in terms of manufacturing processes and capacity.
The facility will process only New Zealand sourced material and enable Proliant to supply the world with New Zealand BSA.